Geovax Labs Inc. (GOVX) Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program

Go back to Geovax Labs Inc. (GOVX) Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program
GeoVax Labs, Inc. (NASDAQ: GOVX) Delayed: 2.26 +0.09 (4.15%)
Previous Close $2.17    52 Week High $0.14 
Open $2.16    52 Week Low $0.05 
Day High $2.26    P/E N/A 
Day Low $2.16    EPS $-0.14 
Volume 40,160       

(NASDAQ: GOVXW) Delayed: 0.80 --0 (-0%)
Previous Close $0.80    52 Week High
Open $0.80    52 Week Low
Day High $0.80    P/E N/A 
Day Low $0.80    EPS
Volume